339 related articles for article (PubMed ID: 11469636)
1. The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system.
Skyler JS
Diabetes Technol Ther; 2000; 2 Suppl 1():S7-12. PubMed ID: 11469636
[No Abstract] [Full Text] [Related]
2. Efficacy and reliability of the continuous glucose monitoring system.
Gross TM; Mastrototaro JJ
Diabetes Technol Ther; 2000; 2 Suppl 1():S19-26. PubMed ID: 11469628
[No Abstract] [Full Text] [Related]
3. Continuous glucose monitoring in youth with type 2 diabetes: overcoming barriers to successful treatment.
Boland EA; Tamborlane WV
Diabetes Technol Ther; 2000; 2 Suppl 1():S53-9. PubMed ID: 11469633
[No Abstract] [Full Text] [Related]
4. Self-monitoring of blood glucose in diabetes.
Drug Ther Bull; 2007 Sep; 45(9):65-9. PubMed ID: 17894194
[TBL] [Abstract][Full Text] [Related]
5. Continuous glucose monitoring system--useful but expensive tool in management of diabetes.
Vidhya K; Sudhir R; Mohan V
J Assoc Physicians India; 2004 Jul; 52():587-90. PubMed ID: 15645991
[TBL] [Abstract][Full Text] [Related]
6. Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine).
Edelman SV; Callahan P; Deeb LC
Diabetes Technol Ther; 2000; 2(2):233-8. PubMed ID: 11469264
[TBL] [Abstract][Full Text] [Related]
7. The impact of continuous glucose monitoring on hospital point-of-care testing programs.
Kiechle FL
Diabetes Technol Ther; 2001; 3(4):647-50. PubMed ID: 11911179
[No Abstract] [Full Text] [Related]
8. Clinical utility of the continuous glucose monitoring system.
Bode BW
Diabetes Technol Ther; 2000; 2 Suppl 1():S35-41. PubMed ID: 11469630
[No Abstract] [Full Text] [Related]
9. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.
Gallieni M; De Salvo C; Lunati ME; Rossi A; D'Addio F; Pastore I; Sabiu G; Miglio R; Zuccotti GV; Fiorina P
Acta Diabetol; 2021 Aug; 58(8):975-981. PubMed ID: 33743082
[TBL] [Abstract][Full Text] [Related]
10. Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus.
Lin R; Brown F; James S; Jones J; Ekinci E
Diabet Med; 2021 May; 38(5):e14528. PubMed ID: 33496979
[TBL] [Abstract][Full Text] [Related]
11. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC).
Herman WH; Braffett BH; Kuo S; Lee JM; Brandle M; Jacobson AM; Prosser LA; Lachin JM
J Diabetes Complications; 2018 Oct; 32(10):934-939. PubMed ID: 30064713
[TBL] [Abstract][Full Text] [Related]
12. Continuous glucose monitoring and type 1 diabetes.
Finlayson AE; Cronin NJ; Choudhary P
N Engl J Med; 2009 Jan; 360(2):191; author reply 191-2. PubMed ID: 19137629
[No Abstract] [Full Text] [Related]
13. Continuous glucose monitoring in previously unstudied population subgroups.
Gross TM; Ter Veer A
Diabetes Technol Ther; 2000; 2 Suppl 1():S27-34. PubMed ID: 11469629
[No Abstract] [Full Text] [Related]
14. The problem with ADAGE (A1c-derived average glucose equivalent).
Treviño G
MedGenMed; 2007 Nov; 9(4):43. PubMed ID: 18311393
[No Abstract] [Full Text] [Related]
15. Practical aspects of real-time continuous glucose monitoring.
Gilliam LK; Hirsch IB
Diabetes Technol Ther; 2009 Jun; 11 Suppl 1():S75-82. PubMed ID: 19469681
[TBL] [Abstract][Full Text] [Related]
16. Self-Monitoring of Blood Glucose.
Garg SK; Hirsch IB
Diabetes Technol Ther; 2019 Feb; 21(S1):S4-S12. PubMed ID: 30785324
[No Abstract] [Full Text] [Related]
17. Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system.
Jungheim K; Wientjes KJ; Heinemann L; Lodwig V; Koschinsky T; Schoonen AJ;
Diabetes Care; 2001 Sep; 24(9):1696-7. PubMed ID: 11522729
[No Abstract] [Full Text] [Related]
18. [It is worth concentrating on prevention of complications. An example from diabetic care].
Tennvall GR; Rosenqvist U; Nilsson LG
Lakartidningen; 1997 Aug; 94(34):2817-21. PubMed ID: 9303991
[No Abstract] [Full Text] [Related]
19. Continuous glucose monitoring and intensive treatment of type 1 diabetes.
; Tamborlane WV; Beck RW; Bode BW; Buckingham B; Chase HP; Clemons R; Fiallo-Scharer R; Fox LA; Gilliam LK; Hirsch IB; Huang ES; Kollman C; Kowalski AJ; Laffel L; Lawrence JM; Lee J; Mauras N; O'Grady M; Ruedy KJ; Tansey M; Tsalikian E; Weinzimer S; Wilson DM; Wolpert H; Wysocki T; Xing D
N Engl J Med; 2008 Oct; 359(14):1464-76. PubMed ID: 18779236
[TBL] [Abstract][Full Text] [Related]
20. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
Bragd J; Adamson U; Bäcklund LB; Lins PE; Moberg E; Oskarsson P
Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
